ARCHIVES

EORTC Places Same Number on Phase 2-3 Trials As In U.S.

This article is from The Cancer Letter archive.

Vol. 12 No. 48 | December 12, 1986

Download PDF Visit The Full Archive

Related Articles

In Brief: Marks’ Appointment As President, Chief Executive Officer Of Memorial Sloan-Kettering, Official

June 27, 1980

DCBD Board Okays Concept For New Cytogenetics RFA

August 3, 1984

NIH Revises Application Receipt Dates

November 22, 1985

Funding Opportunities Listed.

January 14, 2005

Tighter Payment Policy

November 5, 2010

Conversation With The Cancer Letter: Wicha to Leave Director’s Job at UMich

November 8, 2013